Clinic to commercialization for a wide range of modalities
A tailored approach to drug substance manufacturing to suit your molecule needs
Benefit from access to Lonza’s extensive experience in cGMP drug substance manufacturing across a variety of modalities from clinic to commercialization.We have the flexibility to use our global network and capabilities to tailor our suite of services to your molecule wherever you are in your molecule lifecycle. Our range of bioreactors across our network offer non-GMP pilot capabilities and cGMP scales. This allows us to support you in choosing the appropriate scale and scale-up strategy that best suits your clinical path, mid and long-term demand and commercialization strategy. You can also benefit from our extensive BLA experience.